Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sanofi-Aventis |
---|---|
Information provided by: | Sanofi-Aventis |
ClinicalTrials.gov Identifier: | NCT00347490 |
Primary objective:
To assess clinical efficacy of single bolus anticoagulation with Enoxaparin in chronic hemodialysis
Secondary objective:
To assess safety and tolerability by the number of spontaneously reported adverse events by patients
Condition | Intervention | Phase |
---|---|---|
Hemodialysis |
Drug: Enoxaparine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Efficacy and Safety in Hemodialysis With Enoxaparine |
Estimated Enrollment: | 100 |
Study Start Date: | May 2006 |
Study Completion Date: | June 2007 |
Primary Completion Date: | April 2007 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contraindication to anticoagulation:
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study ID Numbers: | ENOXA_L_00821 |
Study First Received: | June 30, 2006 |
Last Updated: | January 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00347490 |
Health Authority: | Thailand: Ministry of Public Health |
Enoxaparin |
Fibrin Modulating Agents Anticoagulants Molecular Mechanisms of Pharmacological Action Therapeutic Uses |
Hematologic Agents Fibrinolytic Agents Cardiovascular Agents Pharmacologic Actions |